High grade B-cell lymphoma with MYC and BCL6 rearrangements

Clinical trials for High grade B-cell lymphoma with MYC and BCL6 rearrangements explained in plain language.

Never miss a new study

Get alerted when new High grade B-cell lymphoma with MYC and BCL6 rearrangements trials appear

Sign up with your email to follow new studies for High grade B-cell lymphoma with MYC and BCL6 rearrangements, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug cocktail ViPOR targets tough lymphomas in phase II trial

Disease control Recruiting now

This phase II trial is testing a combination of five drugs (venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide, called ViPOR) in people with certain aggressive B-cell lymphomas that have come back or not responded to treatment. The study aims to see how many patien…

Matched conditions: HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL6 REARRANGEMENTS

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Sep 12, 2026 00:00 UTC

High grade B-cell lymphoma with MYC and BCL6 rearrangements

Get alerted when new High grade B-cell lymphoma with MYC and BCL6 rearrangements trials appear

New drug cocktail ViPOR targets tough lymphomas in phase II trial